6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Motivational Deficits in Addiction Recovery
Motivational deficits are common barriers in addiction recovery, often rooted in the brain's altered reward system. Prolonged substance use diminishes the ability to find pleasure in everyday activities, leading to apathy and low drive. These deficits hinder individuals from engaging in treatment, setting goals, and maintaining long-term sobriety. Motivational Enhancement Therapy (MET) and other evidence-based approaches are vital in reigniting intrinsic motivation. By focusing on personal values and the benefits of recovery, these therapies help individuals overcome feelings of helplessness. Addressing motivational deficits requires a multifaceted approach, combining psychological support, social reinforcement, and skill-building to instill hope and encourage positive behavioral change.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States